Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper.
Rizzoli R, Body JJ, DeCensi A, Reginster JY, Piscitelli P, Brandi ML; European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO). Rizzoli R, et al. Among authors: decensi a. Osteoporos Int. 2012 Nov;23(11):2567-76. doi: 10.1007/s00198-011-1870-0. Epub 2012 Jan 20. Osteoporos Int. 2012. PMID: 22270857
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Among authors: decensi a. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study.
Bottoni G, Fiz F, Puntoni M, Matteucci F, Monti M, DeCensi A, Nanni O, Brain E, Alberini JL, Dib B, Sacchetti G, Trimboli P, Treglia G, Harbeck N, Sola S, Gennari A, Piccardo A. Bottoni G, et al. Among authors: decensi a. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2477-2485. doi: 10.1007/s00259-023-06173-9. Epub 2023 Mar 7. Eur J Nucl Med Mol Imaging. 2023. PMID: 36879065
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.
Guerrieri-Gonzaga A, Serrano D, Gnagnarella P, Johansson H, Zovato S, Nardi M, Pensabene M, Buccolo S, DeCensi A, Briata IM, Pistelli L, Sansone C, Mannucci S, Aristarco V, Macis D, Lazzeroni M, Aurilio G, Accornero CA, Gandini S, Bonanni B. Guerrieri-Gonzaga A, et al. Among authors: decensi a. PLoS One. 2024 Sep 3;19(9):e0309511. doi: 10.1371/journal.pone.0309511. eCollection 2024. PLoS One. 2024. PMID: 39226292 Free PMC article.
Serum Biomarkers to Dynamically Predict the Risk of Cardiovascular Events in Patients under Oncologic Therapy. A Multicenter Observational Study.
Provinciali N, Piccininno M, Siri G, Gennari A, Antonucci G, Ricci D, Devoto E, Miceli R, Cortesi P, Pazzi C, Nanni O, Mannozzi F, Pastina I, Messuti L, Bengala C, Frassineti GL, Cattrini C, Fava M, Buttiron Webber T, Briata IM, Corradengo D, DeCensi A, Puntoni M. Provinciali N, et al. Among authors: decensi a. Rev Cardiovasc Med. 2024 Jul 9;25(7):256. doi: 10.31083/j.rcm2507256. eCollection 2024 Jul. Rev Cardiovasc Med. 2024. PMID: 39139415 Free PMC article.
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.
Serrano D, Johansson H, Bertelsen BE, Gandini S, Mellgren G, Thomas P, Crew KD, Kumar NB, Macis D, Aristarco V, Guerrieri-Gonzaga A, Lazzeroni M, D'Amico M, Buttiron-Webber T, Briata IM, Spinaci S, Galimberti V, Vornik LA, Villar-Sanchez E, Brown PH, Heckman-Stoddard BM, Szabo E, Bonanni B, Decensi A. Serrano D, et al. Among authors: decensi a. J Natl Cancer Inst. 2024 Aug 7:djae183. doi: 10.1093/jnci/djae183. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39110531
Role of 64CuCl2 PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and 18F-FDG PET/CT.
Piccardo A, Bottoni G, Puppo C, Massollo M, Ugolini M, Shoushtari Zadeh Naseri M, Melani E, Tomasello L, Boitano M, DeCensi A, Sambucco B, Campodonico F, Altrinetti V, Ennas M, Urru A, Negro CLA, Timossi L, Treglia G, Introini C, Fiz F. Piccardo A, et al. Among authors: decensi a. J Nucl Med. 2024 Sep 3;65(9):1357-1363. doi: 10.2967/jnumed.124.267474. J Nucl Med. 2024. PMID: 39054284
A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial.
Macis D, Bellerba F, Aristarco V, Johansson H, Guerrieri-Gonzaga A, Lazzeroni M, Sestak I, Cuzick J, DeCensi A, Bonanni B, Gandini S. Macis D, et al. Among authors: decensi a. Nutrients. 2024 Jun 30;16(13):2098. doi: 10.3390/nu16132098. Nutrients. 2024. PMID: 38999846 Free PMC article. Clinical Trial.
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.
Mc Laughlin AM, Helland T, Klima F, Koolen SLW, van Schaik RHN, Mathijssen RHJ, Neven P, Swen JJ, Guchelaar HJ, Dalenc F, White-Koning M, Michelet R, Mikus G, Schroth W, Mürdter T, Brauch H, Schwab M, Søiland H, Mellgren G, Thomas F, Kloft C, Hertz DL; CYP2D6 Endoxifen Percentage Activity Model (CEPAM) Consortium. Mc Laughlin AM, et al. Clin Pharmacol Ther. 2024 Sep;116(3):690-702. doi: 10.1002/cpt.3238. Epub 2024 Mar 18. Clin Pharmacol Ther. 2024. PMID: 38494911
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials.
Johansson H, Bellerba F, Macis D, Bertelsen BE, Guerrieri-Gonzaga A, Aristarco V, Viste K, Mellgren G, Di Cola G, Costantino J, Scalbert A, Sears DD, Gandini S, DeCensi A, Bonanni B. Johansson H, et al. Among authors: decensi a. Breast Cancer Res Treat. 2024 May;205(1):49-59. doi: 10.1007/s10549-023-07241-2. Epub 2024 Jan 26. Breast Cancer Res Treat. 2024. PMID: 38279016 Free PMC article. Clinical Trial.
255 results